{
    "allele": {
        "alpha": {
            "identifier": "ipd-imgt:HLA35266",
            "locus": "hla-a",
            "match_type": "histo:exact",
            "name": "HLA-A*02:01",
            "slug": "hla_a_02_01",
            "species_stem": "hla"
        },
        "beta": {}
    },
    "assemblies": {
        "1": {
            "assembly_name": "4wj5_1",
            "chains": [
                "A",
                "B",
                "C"
            ],
            "downloaded_at": "2022-11-09T14:33:47.604806"
        },
        "2": {
            "assembly_name": "4wj5_2",
            "chains": [
                "D",
                "E",
                "F"
            ],
            "downloaded_at": "2022-11-09T14:33:48.065057"
        }
    },
    "assembly_count": null,
    "assigned_chains": {
        "beta2m": {
            "chains": [
                "B",
                "E"
            ],
            "match_type": "histo:assign_chains",
            "score": 0.99,
            "sequence": "MIQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLLKNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYACRVNHVTLSQPKIVKWDRDM"
        },
        "class_i_alpha": {
            "chains": [
                "A",
                "D"
            ],
            "match_type": "histo:assign_chains",
            "score": 1.0,
            "sequence": "GSHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRWE"
        },
        "peptide": {
            "chains": [
                "C",
                "F"
            ],
            "match_type": "histo:classify_peptide",
            "sequence": "XVAGIGILTX"
        }
    },
    "chronology": {
        "deposition_date": "2014-09-29",
        "deposition_year": 2014,
        "release_date": "2014-10-29",
        "release_year": 2014,
        "revision_date": "2014-11-19",
        "revision_year": 2014
    },
    "class": "class_i",
    "classical": true,
    "complex_type": "class_i_with_peptide",
    "components": [
        "class_i_alpha",
        "beta2m",
        "peptide"
    ],
    "experimental_method": "X-ray diffraction",
    "facets": {},
    "ligands": [],
    "locus": "hla-a",
    "manually_edited": {},
    "missing_residues": [],
    "page_title": "4WJ5 | HLA-A*02:01 binding \"XVAGIGILTX\"",
    "pdb_code": "4wj5",
    "pdb_title": "Structure of hla-a2 in complex with an altered peptide ligands based on mart-1 variant epitope",
    "peptide": {
        "C": {
            "actual_length": 8,
            "actual_sequence": "XAGIGILT",
            "chain_id": "C",
            "features": [
                "contains_unnatural",
                "central_gap"
            ],
            "full_length": 10,
            "full_sequence": "XVAGIGILTX",
            "gapped_sequence": "XAGIGILT"
        },
        "F": {
            "actual_length": 8,
            "actual_sequence": "XAGIGILT",
            "chain_id": "F",
            "features": [
                "contains_unnatural",
                "central_gap"
            ],
            "full_length": 10,
            "full_sequence": "XVAGIGILTX",
            "gapped_sequence": "XAGIGILT"
        }
    },
    "peptide_length": 10,
    "peptide_length_name": "decamer",
    "peptide_sequence": "XVAGIGILTX",
    "publication": {
        "abstract": "Virus or tumor Ag-derived peptides that are displayed by MHC class I molecules are attractive starting points for vaccine development because they induce strong protective and therapeutic cytotoxic T cell responses. In thus study, we show that the MHC binding and consequent T cell reactivity against several HLA-A*02 restricted epitopes can be further improved through the incorporation of nonproteogenic amino acids at primary and secondary anchor positions. We screened more than 90 nonproteogenic, synthetic amino acids through a range of epitopes and tested more than 3000 chemically enhanced altered peptide ligands (CPLs) for binding affinity to HLA-A*0201. With this approach, we designed CPLs of viral epitopes, of melanoma-associated Ags, and of the minor histocompatibility Ag UTA2-1, which is currently being evaluated for its antileukemic activity in clinical dendritic cell vaccination trials. The crystal structure of one of the CPLs in complex with HLA-A*0201 revealed the molecular interactions likely responsible for improved binding. The best CPLs displayed enhanced affinity for MHC, increasing MHC stability and prolonging recognition by Ag-specific T cells and, most importantly, they induced accelerated expansion of antitumor T cell frequencies in vitro and in vivo as compared with the native epitope. Eventually, we were able to construct a toolbox of preferred nonproteogenic residues with which practically any given HLA-A*02 restricted epitope can be readily optimized. These CPLs could improve the therapeutic outcome of vaccination strategies or can be used for ex vivo enrichment and faster expansion of Ag-specific T cells for transfer into patients.",
        "bibjson": {
            "author": [
                {
                    "initials": "R",
                    "lastname": "Hoppes",
                    "name": "Hoppes R"
                },
                {
                    "initials": "R",
                    "lastname": "Oostvogels",
                    "name": "Oostvogels R"
                },
                {
                    "initials": "JJ",
                    "lastname": "Luimstra",
                    "name": "Luimstra JJ"
                },
                {
                    "initials": "K",
                    "lastname": "Wals",
                    "name": "Wals K"
                },
                {
                    "initials": "M",
                    "lastname": "Toebes",
                    "name": "Toebes M"
                },
                {
                    "initials": "L",
                    "lastname": "Bies",
                    "name": "Bies L"
                },
                {
                    "initials": "R",
                    "lastname": "Ekkebus",
                    "name": "Ekkebus R"
                },
                {
                    "initials": "P",
                    "lastname": "Rijal",
                    "name": "Rijal P"
                },
                {
                    "initials": "PH",
                    "lastname": "Celie",
                    "name": "Celie PH"
                },
                {
                    "initials": "JH",
                    "lastname": "Huang",
                    "name": "Huang JH"
                },
                {
                    "initials": "ME",
                    "lastname": "Emmelot",
                    "name": "Emmelot ME"
                },
                {
                    "initials": "RM",
                    "lastname": "Spaapen",
                    "name": "Spaapen RM"
                },
                {
                    "initials": "H",
                    "lastname": "Lokhorst",
                    "name": "Lokhorst H"
                },
                {
                    "initials": "TN",
                    "lastname": "Schumacher",
                    "name": "Schumacher TN"
                },
                {
                    "initials": "T",
                    "lastname": "Mutis",
                    "name": "Mutis T"
                },
                {
                    "initials": "B",
                    "lastname": "Rodenko",
                    "name": "Rodenko B"
                },
                {
                    "initials": "H",
                    "lastname": "Ovaa",
                    "name": "Ovaa H"
                }
            ],
            "identifier": [
                {
                    "id": "10.4049/jimmunol.1400800",
                    "type": "doi"
                },
                {
                    "id": "25311806",
                    "type": "pubmed"
                }
            ],
            "issue": [
                null
            ],
            "journal": {
                "iso_abbreviation": "J. Immunol.",
                "name": ""
            },
            "pages": [
                null
            ],
            "title": "Altered Peptide Ligands Revisited: Vaccine Design through Chemically Modified HLA-A2-Restricted T Cell Epitopes.",
            "type": "article",
            "url": "http://www.jimmunol.org/lookup/doi/10.4049/jimmunol.1400800",
            "volume": [
                null
            ],
            "year": [
                2014
            ]
        },
        "in_pmc": "N",
        "in_pmce": "Y",
        "open_access": "N"
    },
    "resolution": "1.65",
    "same_as": {
        "pdbe": {
            "url": "https://www.ebi.ac.uk/pdbe/entry/pdb/4wj5"
        },
        "rcsb": {
            "url": "https://www.rcsb.org/structure/4wj5"
        }
    },
    "species": {
        "common_name": "Human",
        "match_type": "histo:assign_species",
        "scientific_name": "Homo sapiens",
        "slug": "homo_sapiens"
    },
    "tcr": null,
    "title": "HLA-A*02:01 binding \"XVAGIGILTX\" at 1.65&#8491; resolution",
    "unique_chain_count": 3
}